The adjustment for CMR resulted in significant strengthening of the association, which indirectly demonstrated an important role of O-acetylation in the activation of bladder carcinogens, leading to elevated risk of bladder cancer for individuals who carried high functional alleles of the NAT2 gene. The gene discussed is NAT2; the disease is urinary bladder cancer.